CNO
CNO Financial Group, Inc.
Price Chart
Latest Quote
$53.59
| Previous Close | $53.51 |
| Open | $53.32 |
| Day High | $54.09 |
| Day Low | $53.12 |
| Volume | 399,529 |
Stock Information
| Quarterly Dividend / Yield | $0.72 / 1.38% |
| Shares Outstanding | 93.35M |
| Quarterly Dividend Yield | 1.38% |
| Quarterly Dividend | $0.72 |
| Total Debt | $4.30B |
| Cash Equivalents | $1.41B |
| Revenue | $4.51B |
| Net Income | $245.50M |
| Sector | Financial Services |
| Industry | Insurance - Life |
| Market Cap | $4.95B |
| P/E Ratio | 21.39 |
| EPS (TTM) | $2.48 |
| Exchange | NYQ |
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $53.59 | 589,600 |
| 2026-07-16 | $53.51 | 715,600 |
| 2026-07-15 | $52.75 | 729,100 |
| 2026-07-14 | $52.19 | 1,014,800 |
| 2026-07-13 | $52.20 | 861,700 |
| 2026-07-10 | $51.96 | 1,044,000 |
| 2026-07-09 | $52.93 | 502,400 |
| 2026-07-08 | $52.40 | 473,400 |
| 2026-07-07 | $52.89 | 764,600 |
| 2026-07-06 | $52.64 | 712,800 |
| 2026-07-02 | $52.43 | 628,200 |
| 2026-07-01 | $52.07 | 932,400 |
| 2026-06-30 | $50.98 | 1,870,800 |
| 2026-06-29 | $52.13 | 674,100 |
| 2026-06-26 | $52.52 | 3,028,600 |
| 2026-06-25 | $51.90 | 834,500 |
| 2026-06-24 | $52.14 | 983,600 |
| 2026-06-23 | $52.77 | 641,900 |
| 2026-06-22 | $51.46 | 610,200 |
| 2026-06-18 | $50.83 | 1,519,800 |
About CNO Financial Group, Inc.
CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance and other insurance products, and financial services for middle-income pre-retiree and retired Americans in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individual consumers through phone, virtually, online, and face-to-face with agents. The company also focuses on sale of voluntary benefit life and health insurance products for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed indexed annuities; fixed interest annuities, including fixed rate single-premium deferred annuities; flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees, lesser degree, and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. It markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company was founded in 1979 and is headquartered in Carmel, Indiana.
đ° Latest News
Zacks Industry Outlook Highlights Oscar Health, Radian, CNO Financial, Pelagos Insurance Capital and Horace Mann Educators
Zacks âĸ 2026-07-16T07:17:00ZCNO Financial Group (CNO) Gains Momentum, Is It Fully Priced?
Simply Wall St. âĸ 2026-07-16T07:11:49Z5 Multiline Insurers to Buy Amid Inflation, Softening Pricing
Zacks âĸ 2026-07-15T17:42:00ZPRU Outperforms Industry, Trades at a Discount: Time to Exit or Hold?
Zacks âĸ 2026-07-15T16:36:00ZHow AI Is Becoming MetLife's Long-Term Competitive Advantage
Zacks âĸ 2026-07-15T14:19:00ZAccelerant Advances Fee-Based Model With WoodStar Partnership
Zacks âĸ 2026-07-14T13:55:00ZHere's Why Accelerant Shares Are Attracting Prudent Investors Now
Zacks âĸ 2026-07-08T17:18:00Z3 Hyped Up Stocks with Questionable Fundamentals
StockStory âĸ 2026-07-07T11:05:52ZCNO Financial Group (CNO): Buy, Sell, or Hold Post Q1 Earnings?
StockStory âĸ 2026-07-06T14:36:01ZPFG Outperforms Industry, Trades Near 52-Week High: Time to Exit?
Zacks âĸ 2026-06-30T16:30:00ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $4,487,400,000 | $4,445,600,000 | $4,146,800,000 | $3,576,800,000 |
| Operating Revenue | $4,487,400,000 | $4,445,600,000 | $4,146,800,000 | $3,576,800,000 |
| Expenses | ||||
| Interest Expense | $230,900,000 | $254,400,000 | $238,600,000 | $137,000,000 |
| Total Expenses | $4,194,000,000 | $3,905,700,000 | $3,790,000,000 | $2,760,300,000 |
| Net Non Operating Interest Income Expense | $-230,900,000 | $-254,400,000 | $-238,600,000 | $-137,000,000 |
| Interest Expense Non Operating | $230,900,000 | $254,400,000 | $238,600,000 | $137,000,000 |
| Other Operating Expenses | $680,000,000 | $629,000,000 | $646,300,000 | $548,800,000 |
| General And Administrative Expense | $305,000,000 | $304,500,000 | $290,900,000 | $287,900,000 |
| Loss Adjustment Expense | $2,465,100,000 | $2,348,700,000 | $2,275,700,000 | $1,459,600,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $229,300,000 | $420,800,000 | $276,500,000 | $630,600,000 |
| Net Interest Income | $-230,900,000 | $-254,400,000 | $-238,600,000 | $-137,000,000 |
| Normalized Income | $307,712,400 | $417,758,000 | $276,500,000 | $630,600,000 |
| Net Income From Continuing And Discontinued Operation | $229,300,000 | $420,800,000 | $276,500,000 | $630,600,000 |
| Net Income Common Stockholders | $229,300,000 | $420,800,000 | $276,500,000 | $630,600,000 |
| Net Income | $229,300,000 | $420,800,000 | $276,500,000 | $630,600,000 |
| Net Income Including Noncontrolling Interests | $229,300,000 | $420,800,000 | $276,500,000 | $630,600,000 |
| Net Income Continuous Operations | $229,300,000 | $420,800,000 | $276,500,000 | $630,600,000 |
| Pretax Income | $293,400,000 | $539,900,000 | $356,800,000 | $816,500,000 |
| Special Income Charges | $-100,400,000 | $3,900,000 | $0 | $0 |
| Depreciation And Amortization In Income Statement | - | - | - | $309,600,000 |
| Per Share | ||||
| Diluted EPS | $2.30 | $3.74 | $2.40 | $3.37 |
| Basic EPS | $2.35 | $3.81 | $2.44 | $3.43 |
| Other | ||||
| Tax Effect Of Unusual Items | $-21,987,600 | $858,000 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Total Unusual Items | $-100,400,000 | $3,900,000 | $0 | $0 |
| Total Unusual Items Excluding Goodwill | $-100,400,000 | $3,900,000 | $0 | $0 |
| Reconciled Depreciation | $318,500,000 | $292,400,000 | $267,400,000 | $248,500,000 |
| EBIT | $524,300,000 | $794,300,000 | $595,400,000 | $953,500,000 |
| Diluted Average Shares | $99,822,000 | $108,116,000 | $115,124,000 | $117,717,000 |
| Basic Average Shares | $97,763,000 | $106,144,000 | $113,275,000 | $115,733,000 |
| Diluted NI Availto Com Stockholders | $229,300,000 | $420,800,000 | $276,500,000 | $630,600,000 |
| Tax Provision | $64,100,000 | $119,100,000 | $80,300,000 | $185,900,000 |
| Other Special Charges | $-1,500,000 | $-3,900,000 | - | - |
| Impairment Of Capital Assets | $101,900,000 | $0 | $0 | - |
| Selling General And Administration | $305,000,000 | $304,500,000 | $290,900,000 | $287,900,000 |
| Salaries And Wages | $305,000,000 | $304,500,000 | $290,900,000 | $287,900,000 |
| Net Policyholder Benefits And Claims | $2,465,100,000 | $2,348,700,000 | $2,275,700,000 | $1,459,600,000 |
| Amortization | - | - | - | $309,600,000 |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $2,638,200,000 | $2,515,200,000 | $2,215,600,000 | $1,768,800,000 |
| Total Assets | $38,790,600,000 | $37,849,300,000 | $35,027,100,000 | $33,133,100,000 |
| Receivables | $4,390,800,000 | $4,668,800,000 | $4,976,900,000 | $5,286,800,000 |
| Taxes Receivable | $713,300,000 | $814,100,000 | $936,200,000 | $1,063,400,000 |
| Accounts Receivable | $3,677,500,000 | $3,854,700,000 | $4,040,700,000 | $4,223,400,000 |
| Cash Cash Equivalents And Short Term Investments | $8,578,300,000 | $24,386,800,000 | $22,280,700,000 | $20,422,600,000 |
| Cash And Cash Equivalents | $956,100,000 | $1,656,700,000 | $774,500,000 | $69,200,000 |
| Debt | ||||
| Net Debt | $3,095,600,000 | $2,863,200,000 | $3,376,100,000 | $3,813,700,000 |
| Total Debt | $4,051,700,000 | $4,519,900,000 | $4,150,600,000 | $3,882,900,000 |
| Long Term Debt And Capital Lease Obligation | $4,051,700,000 | $4,519,900,000 | $4,150,600,000 | $3,882,900,000 |
| Long Term Debt | $4,051,700,000 | $4,519,900,000 | $4,150,600,000 | $3,882,900,000 |
| Current Debt And Capital Lease Obligation | - | - | $0 | $0 |
| Current Debt | - | - | $0 | $0 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $36,152,400,000 | $35,334,100,000 | $32,811,500,000 | $31,364,300,000 |
| Equity | ||||
| Common Stock Equity | $2,638,200,000 | $2,515,200,000 | $2,215,600,000 | $1,768,800,000 |
| Total Equity Gross Minority Interest | $2,638,200,000 | $2,515,200,000 | $2,215,600,000 | $1,768,800,000 |
| Stockholders Equity | $2,638,200,000 | $2,515,200,000 | $2,215,600,000 | $1,768,800,000 |
| Gains Losses Not Affecting Retained Earnings | $-1,115,000,000 | $-1,371,400,000 | $-1,576,800,000 | $-1,957,300,000 |
| Other Equity Adjustments | $-1,115,000,000 | $-1,371,400,000 | $-1,576,800,000 | $-1,957,300,000 |
| Retained Earnings | $2,416,000,000 | $2,253,100,000 | $1,899,800,000 | $1,691,200,000 |
| Long Term Equity Investment | $293,000,000 | $433,800,000 | $768,600,000 | $1,077,600,000 |
| Investments In Other Ventures Under Equity Method | $293,000,000 | $433,800,000 | $768,600,000 | $1,077,600,000 |
| Other | ||||
| Ordinary Shares Number | $94,484,339 | $101,618,957 | $109,357,540 | $114,343,070 |
| Share Issued | $94,484,339 | $101,618,957 | $109,357,540 | $114,343,070 |
| Tangible Book Value | $2,638,200,000 | $2,515,200,000 | $2,215,600,000 | $1,768,800,000 |
| Invested Capital | $6,689,900,000 | $7,035,100,000 | $6,366,200,000 | $5,651,700,000 |
| Total Capitalization | $6,689,900,000 | $7,035,100,000 | $6,366,200,000 | $5,651,700,000 |
| Additional Paid In Capital | $1,336,300,000 | $1,632,500,000 | $1,891,500,000 | $2,033,800,000 |
| Capital Stock | $900,000 | $1,000,000 | $1,100,000 | $1,100,000 |
| Common Stock | $900,000 | $1,000,000 | $1,100,000 | $1,100,000 |
| Investments And Advances | $24,863,800,000 | $23,740,500,000 | $22,594,400,000 | $21,774,200,000 |
| Other Short Term Investments | $7,622,200,000 | $22,730,100,000 | $21,506,200,000 | $20,353,400,000 |
| Line Of Credit | - | - | $0 | $0 |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $675,700,000 | $627,700,000 | $582,900,000 | $495,400,000 |
| Operating Activities | ||||
| Operating Cash Flow | $675,700,000 | $627,700,000 | $582,900,000 | $495,400,000 |
| Cash Flow From Continuing Operating Activities | $675,700,000 | $627,700,000 | $582,900,000 | $495,400,000 |
| Operating Gains Losses | $54,700,000 | $49,900,000 | $69,000,000 | $135,400,000 |
| Investing Activities | ||||
| Investing Cash Flow | $-1,667,300,000 | $-1,488,600,000 | $-872,300,000 | $-1,781,300,000 |
| Cash Flow From Continuing Investing Activities | $-1,667,300,000 | $-1,488,600,000 | $-872,300,000 | $-1,781,300,000 |
| Net Other Investing Changes | $-3,200,000 | $-13,500,000 | $-36,600,000 | $-61,200,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-331,400,000 | $-300,200,000 | $-166,100,000 | $-190,100,000 |
| Issuance Of Capital Stock | $11,600,000 | $11,200,000 | $13,200,000 | $13,500,000 |
| Financing Cash Flow | $-22,600,000 | $1,969,600,000 | $533,500,000 | $1,199,100,000 |
| Cash Flow From Continuing Financing Activities | $-22,600,000 | $1,969,600,000 | $533,500,000 | $1,199,100,000 |
| Net Other Financing Charges | $848,400,000 | $1,970,700,000 | $495,800,000 | $1,561,200,000 |
| Cash Dividends Paid | $-66,200,000 | $-67,700,000 | $-68,100,000 | $-64,800,000 |
| Common Stock Dividend Paid | $-66,200,000 | $-67,700,000 | $-68,100,000 | $-64,800,000 |
| Net Common Stock Issuance | $-319,800,000 | $-289,000,000 | $-152,900,000 | $-176,600,000 |
| Common Stock Issuance | $11,600,000 | $11,200,000 | $13,200,000 | $13,500,000 |
| Other | ||||
| Repayment Of Debt | $-1,261,800,000 | $-1,223,600,000 | $-736,800,000 | $-405,700,000 |
| Issuance Of Debt | $776,800,000 | $1,579,200,000 | $995,500,000 | $285,000,000 |
| End Cash Position | $983,500,000 | $1,997,700,000 | $889,000,000 | $644,900,000 |
| Beginning Cash Position | $1,997,700,000 | $889,000,000 | $644,900,000 | $731,700,000 |
| Changes In Cash | $-1,014,200,000 | $1,108,700,000 | $244,100,000 | $-86,800,000 |
| Common Stock Payments | $-331,400,000 | $-300,200,000 | $-166,100,000 | $-190,100,000 |
| Net Issuance Payments Of Debt | $-485,000,000 | $355,600,000 | $258,700,000 | $-120,700,000 |
| Net Long Term Debt Issuance | $-485,000,000 | $355,600,000 | $258,700,000 | $-120,700,000 |
| Long Term Debt Payments | $-1,261,800,000 | $-1,223,600,000 | $-736,800,000 | $-405,700,000 |
| Long Term Debt Issuance | $776,800,000 | $1,579,200,000 | $995,500,000 | $285,000,000 |
| Net Investment Purchase And Sale | $-1,664,100,000 | $-1,475,100,000 | $-835,700,000 | $-1,720,100,000 |
| Sale Of Investment | $6,795,400,000 | $5,415,400,000 | $2,785,600,000 | $4,804,300,000 |
| Purchase Of Investment | $-8,459,500,000 | $-6,890,500,000 | $-3,621,300,000 | $-6,524,400,000 |
| Change In Working Capital | $618,100,000 | $534,700,000 | $449,700,000 | $-374,700,000 |
| Other Non Cash Items | $-173,800,000 | $-288,300,000 | $-122,900,000 | $39,600,000 |
| Asset Impairment Charge | $101,900,000 | $0 | $0 | - |
| Amortization Of Securities | $-499,300,000 | $-445,700,000 | $-377,900,000 | $-336,000,000 |
| Deferred Tax | $26,300,000 | $63,900,000 | $21,100,000 | $152,000,000 |
| Deferred Income Tax | $26,300,000 | $63,900,000 | $21,100,000 | $152,000,000 |
| Depreciation And Amortization | $318,500,000 | $292,400,000 | $267,400,000 | $248,500,000 |
| Gain Loss On Investment Securities | $54,700,000 | $49,900,000 | $69,000,000 | $135,400,000 |
| Net Income From Continuing Operations | $229,300,000 | $420,800,000 | $276,500,000 | $630,600,000 |